Welcome to New Editorial Board Members

A Welcome to New Editorial Board Members

I am very happy to announce that the following five distinguished colleagues have agreed to serve in the Editorial Board of Cardiovascular Innovations and Applications:

Cardiovascular Magnetic Resonance Imaging

Jeroen J. Bax

Jeroen J. Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center, Leiden, The Netherlands. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax is President of the European Society of Cardiology Board 2016-2018.

Congenital Heart Disease

Diego Moguillansky

Diego Moguillansky is Assistant Professor at the Congenital Heart Center, University of Florida, Gainesville, Florida, USA. His primary interests are adult congenital heart disease, and transition of care from pediatrics to adulthood in patients with cardiovascular disease.

Interventional Cardiology

Deepak L. Bhatt

Deepak L. Bhatt is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School, Boston, MA, USA. Professor Bhatt specializes in cardiovascular medicine and interventional cardiology.

Antonio Colombo

Antonio Colombo is Director of the Cardiac Catheterization Laboratory at EMO GVM Centro Cuore Columbus and Chief of Invasive Cardiology at San Raffaele Hospital, Milan, Italy. He is a leading innovator and pioneer in interventional cardiology and has contributed significantly to today’s use of coronary stents and defined the role of intravascular ultrasound in this setting.

Thrombosis

Freek W.A. Verheugt

Freek Verheugt is Professor of Cardiology at the Heart-Lung Centre of the University Medical Centre of Nijmegen and Chairman of the Department of Cardiology at Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. His main interests are pharmacological and interventional treatments of acute coronary syndromes and atrial fibrillation.

I would also like to take this opportunity to thank all our board members for their dedication to the journal and I look forward very much to working with them for many years to come.

Richard Conti